Table 2 Validation of Apo-A1 as biomarker for diagnosis (A) and classification (B) of BTCC
From: Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinoma
A | ||
|---|---|---|
Gold standard | Apo-A1 expression | |
| Â | >18.22 ng/ml | <18.22 ng/ml |
BTCC (107) | 98 | 9 |
Benign damage (49) | 7 | 42 |
B | ||
Gold standard | Apo-A1 expression | |
| Â | >29.86 ng/ml | <29.86 ng/ml |
Aggressive BTCC (49) | 41 | 8 |
Low Malignant BTCC (58) | 6 | 52 |